RecallRadar

FDA Drug recall D-0745-2023

NORepinephrine added to 0.9% sodium chloride, 4 mg/250 mL* (16 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc.,…

On 2023-05-31 the FDA classified a Class II recall of NORepinephrine added to 0.9% sodium chloride, 4 mg/250 mL* (16 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc.,… by Central Admixture Pharmacy Services, citing lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0745-2023
ClassificationClass II
Statusterminated
Initiated2023-04-28
Published2023-05-31
Last updated2026-09-13 11:52 UTC
CompanyCentral Admixture Pharmacy Services
DistributionUS

Product

NORepinephrine added to 0.9% sodium chloride, 4 mg/250 mL* (16 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8097-1.

Reason

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Identifiers

code_info
Lot # 37-884510, Exp 05/04/2023; 37-885671, Exp 05/09/2023; 37-886285, Exp 05/11/2023; 37-888322, Exp 05/21/2023; 37-88…Lot # 37-884510, Exp 05/04/2023; 37-885671, Exp 05/09/2023; 37-886285, Exp 05/11/2023; 37-888322, Exp 05/21/2023; 37-888851, Exp 05/22/2023; 37-889840, Exp 05/25/2023; 37-890130, Exp 05/28/2023; 37-890966, Exp 05/30/2023; 37-893529, Exp 06/11/2023; 37-894766, Exp 06/14/2023; 37-895300, 37-895301, Exp 06/18/2023; 37-898521, Exp 06/29/2023; 37-900338, Exp 07/06/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0745-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.